By 2035, the Pharmaceutical Intermediate Market is poised to reach an impressive $75.05 billion, showcasing a robust compound annual growth rate (CAGR) of 3.22%. This growth trajectory highlights the increasing necessity for pharmaceutical intermediates, driven by rising global healthcare demands and a continuous push for innovation in drug development. The market's expansion is fueled by the...